Fact CheckerSign in

NCT02635022Recruiting

Fragility Fracture Liaison Service and Anti-osteoporosis Medication Monitoring Service Study

Fragility Fracture Liaison Service and Anti-osteoporosis Medication Monitoring Service Study in Rural Area

Source: ClinicalTrials.gov · Last updated 23 Dec 2025

Brief summary (registry, in English)

Aims: (1) to Establish the FLS services at the National Taiwan University Hospital Jinshan Branch. (2) To establish a anti-osteoporosis medication management service at Jinshan Branch. Method: From Aug., 2015, a fracture liaison services (FLSs) following the 13 'Capture the Fracture Best Practice Standards' were implemented at the National Taiwan University Hospital Jinshan Branch health care system. The Jinshan Branch program enrolled patient with 1) new hip fracture 2) newly identified vertebral fractures (radiological or clinical) from both inpatients and outpatients. At the same time, a osteoporosis medication management service is also establish as a complement of FLS to enroll patients on antiosteoporosis medications (AOMs) but not necessary with fracture. Participating physicians will select those eligible for services and refer to study coordinators. Study coordinators will conduct baseline assessments on osteoporosis/fracture risks, record medical conditions, AOMs, provide educations on osteoporosis, fracture, sarcopenia, fall, medications, nutrition, and exercise. They also arrange return clinic visit, telephone reminder and follow up for patients, and communicate with providers on regular bases. During the whole study period, the investigators planed to enroll 200 patients (with or without fracture). Each patient would be assessed at baseline, and every 4 months last for two years.

Status (registry)
Recruiting
Study type
Observational
Enrollment
200 (estimated)
First submitted
25 Nov 2015
Start date
Sept 2015
Primary completion date
Dec 2026
Lead sponsor
National Taiwan University Hospital
Diseases
Osteoporosis
NCT number
NCT02635022

What you commit to

  • Study type: Observational
  • Planned participants: 200
  • From Sept 2015 to the primary completion date, Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patient in other medication clinical trials

Other

  • Life expectancy less than 2 years or can't be assessed for communication problems
  • Atypical fractures
  • Unwilling to accept the assessment and treatment

Who the study is looking for

  • Age \>=50 and one of the below
  • New hip fracture in orthopedic ward
  • Newly identified radiographic vertebral fractures from plan films in geriatric ward or clinical vertebral fractures in outpatient clinics
  • Newly prescribed with AOMs
  • Recent change of AOMs
  • Poor adherence to AOMs
  • Participating physicians feel that the service will benefit the patient in overall osteoporosis and medication managements.

Age in the registry: 50 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
National Taiwan University Hospital, Chutung branch
Coordinator of this site? Confirm its status
HsinchuTaiwanRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.